European Society of Cardiology Quality Indicators - Ventricular Arrhythmias and Sudden Cardiac Death - 2022 ESC QIs

Sep 4, 2026

Upload by Mia

Aims to develop a comprehensive suite of quality indicators for the management of patients with ventricular arrhythmias and for preventing sudden cardiac death. The Working Group draws on experts in heart rhythm management, including members linked to the 2022 ESC clinical practice guidelines and the European Heart Rhythm Association. Following the ESC quality indicator development methodology, key domains of care were mapped, candidate indicators were generated through systematic literature review, and final indicators were selected using a modified-Delphi process, with feasibility evaluation included. Eight care domains and 21 QIs are concluded, supporting improved care quality and outcomes and aiding SCD prevention.

LanguageEnglish

CategoryForms

FormatDOCX

Pages47

Reading Time16 min

AccessFree to download

ABSTRACT

Aims

Methods and results

Conclusion

KEYWORDS

INTRODUCTION

Target journal: Europace European Society of Cardiology Quality Indicators for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Developed by the Working Group for Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology. Authors Suleman Aktaa1,2,3,*, Stylianos Tzeis4,*,†, Chris P. Gale1,2,3, Michael J. Ackerman5, Elena Arbelo6-8, Elijah R. Behr9,10, Lia Crotti11,12, Andre d'Avila13, Christian de Chillou14, Thomas Deneke15, Márcio Figueiredo16, Tim Friede17, Christophe Leclercq18, Jose L. Merino19, Chris Semsarian20-22, Axel Verstrael23, Katja Zeppenfeld24, Jacob Tfelt-Hansen25,26, Tobias Reichlin27 *The first two authors contributed equally to the study. Affiliations 1Leeds Institute for Data Analytics, University of Leeds, UK. 2Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK. 3Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK. 4Mitera Hospital, Hygeia Group, Athens, Greece. 5Departments of Cardiovascular Medicine, Pediatric and Adolescent Medicine, and Molecular Pharmacology & Experimental Therapeutics, Divisions of Heart Rhythm Services and Pediatric Cardiology, Windland Smith Rice Genetic Heart Rhythm Clinic and Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, MN, USA. 6Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. 7IDIBAPS, Institut d’Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain. 8Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. 9Cardiovascular Clinical Academic Group and Cardiology Research Centre, St. George’s, University of London, UK. 10St. George’s University Hospitals NHS Foundation Trust, London, UK. 11Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy. 12Departments of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy. 13Director – Cardiac Arrhythmia Service The Harvard Thorndike EP Institute Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA, USA. 14Department of Cardiology, University Hospital Nancy, Vandœuvre lès Nancy, France. 15Heart Center Rhön-Clinic Bad Neustadt, Clinic for interventional Electrophysiology, Germany. 16Cardiology, Electrophysiology Service, University of Campinas (UNICAMP) Hospital, Campinas, Brazil. 17Department of Medical Statistics, University Medical Center Göttingen, Göttingen Germany; and DZHK (German Centre for Cardiovascular Research), partner site Göttingen, Göttingen, Germany. 18University of Rennes, CHU Rennes, LTSI-UMR1099, Rennes, France. 19La Paz University Hospital, IdiPaz, Autonoma University, Madrid, Spain. 20Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, University of Sydney, Sydney, Australia. 21Faculty of Medicine and Health, University of Sydney, Sydney, Australia. 22Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia. 23Patient representative, the ESC Patient Forum, Belgium. 24Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, ZA Leiden, The Netherlands. 25Section of genetics, Department of Forensic Medicine, Faculty of Medical Sciences, University of Copenhagen, Denmark. 26The Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Denmark. 27Department of Cardiology, Inselspial Bern, Bern University Hospital, University of Bern, Bern, Switzerland. †Corresponding author: Stylianos Tzeis Tel: +306973798970 E-mail address: HYPERLINK "mailto:stzeis@otenet.gr" stzeis@otenet.gr ABSTRACT Aims: To develop a suite of quality indicators (QIs) for the management of patients with ventricular arrhythmias (VA) and the prevention of sudden cardiac death (SCD). Methods and results: The Working Group comprised experts in heart rhyt

FAQs

What is the document’s main goal regarding ventricular arrhythmias and sudden cardiac death?

To develop a suite of quality indicators for managing patients with ventricular arrhythmias and preventing sudden cardiac death.

How were the quality indicators developed and selected?

The team followed ESC QI methodology: identifying care domains, creating candidate QIs from systematic literature review, selecting the final set via a modified-Delphi method, and evaluating feasibility.

How many care domains and quality indicators were identified?

Eight domains of care were identified, including 17 main and 4 secondary QIs, yielding 21 QIs in total.

Sep 4, 2026

Upload by Mia